Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.
The item "Deferred-Long-Term-Liabilities" stands at 772.46 Million Hong Kong Dollars as of 12/31/2021, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.45 percent compared to the value the year prior.
The 1 year change in percent is 10.45.
The 3 year change in percent is 52.97.
The 5 year change in percent is 500.40.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Deferred Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Deferred Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Deferred Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Deferred Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Deferred Long Term Liabilities | 280,205,508,085.11 |